Table 4.
5 min HR sub-series | ||||
---|---|---|---|---|
Entire population (46) | Group I (19) | Group II (20) | Group III (7) | |
SDNN | 0.42** | |||
RMSSD | −0.33* | −0.64** | −0.74*** | −0.91** |
STV | −0.48* | |||
LTI | 0.54*** | |||
ApEn | −0.60*** | −0.77*** | ||
SampEn | −0.51*** | −0.66** |
3 min HR sub-series | ||||
---|---|---|---|---|
Entire population (92) | Group I (41) | Group II (42) | Group III (9) | |
SDNN | 0.41*** | |||
RMSSD | −0.28** | −0.66*** | −0.68*** | −0.89** |
Delta | 0.29** | |||
STV | −0.46** | −0.86** | ||
LTI | 0.60*** | 0.44** | 0.33* | 0.87** |
ApEn | −0.69*** | −0.74*** | −0.51*** | |
SampEn | −0.58*** | −0.65*** | −0.36* |
2 min HR sub-series | ||||
---|---|---|---|---|
Entire population (92) | Group I (49) | Group II (42) | Group III (9) | |
SDNN | 0.37*** | |||
RMSSD | −0.32** | −0.55*** | −0.75*** | −0.94*** |
Delta | −0.48** | |||
STV | −0.30* | −0.45** | ||
LTI | 0.54*** | 0.42** | 0.88** | |
ApEn | −0.69*** | −0.74*** | −0.55*** | |
SampEn | −0.65*** | −0.68*** | −0.48** |
p < 0.001,
p < 0.01,
p < 0.05.